AAPL355.63+7.12 (+2.04%) ▲|ABBV294.98+1.09 (+0.37%) ▲|ABT109.29-1.17 (-1.06%) ▼|ACN253.66-4.85 (-1.88%) ▼|ADBE237.60+0.90 (+0.38%) ▲|AMAT395.08+22.55 (+6.05%) ▲|AMD552.90+37.69 (+7.32%) ▲|AMGN468.11+2.88 (+0.62%) ▲|AMT190.24-0.13 (-0.07%) ▼|AMZN266.17-4.70 (-1.74%) ▼|AVGO345.22+13.24 (+3.99%) ▲|AXP323.11-0.35 (-0.11%) ▼|BA174.54+1.16 (+0.67%) ▲|BAC50.67-0.01 (-0.02%) ▼|BKNG160.21+0.95 (+0.60%) ▲|BLK1,226.31+4.16 (+0.34%) ▲|BMY62.91+0.11 (+0.18%) ▲|BNY152.69+1.55 (+1.03%) ▲|BRK-B588.24+4.90 (+0.84%) ▲|C124.21+1.94 (+1.59%) ▲|CAT601.61+17.04 (+2.92%) ▲|CL98.00-0.09 (-0.09%) ▼|CMCSA25.02+0.27 (+1.09%) ▲|COF197.11+1.27 (+0.65%) ▲|COP137.86+2.27 (+1.67%) ▲|COST1,087.61+21.47 (+2.01%) ▲|CRM218.01+4.53 (+2.12%) ▲|CSCO100.76+2.61 (+2.66%) ▲|CVS89.52+0.51 (+0.57%) ▲|CVX213.28+2.06 (+0.98%) ▲|DE691.75+4.11 (+0.60%) ▲|DHR235.31-0.80 (-0.34%) ▼|DIS119.65+0.44 (+0.37%) ▲|DUK128.77-0.17 (-0.13%) ▼|EMR167.06-0.48 (-0.29%) ▼|FDX322.63+3.15 (+0.99%) ▲|GD367.22-0.22 (-0.06%) ▼|GE342.75+4.84 (+1.43%) ▲|GEV808.24+11.20 (+1.41%) ▲|GILD169.73-1.14 (-0.67%) ▼|GM88.90+0.21 (+0.24%) ▲|GOOG290.63+5.71 (+2.00%) ▲|GOOGL293.45+6.07 (+2.11%) ▲|GS926.81+16.62 (+1.83%) ▲|HD351.31+0.31 (+0.09%) ▲|HON227.64-0.58 (-0.25%) ▼|IBM248.22+3.69 (+1.51%) ▲|INTC62.50+4.37 (+7.52%) ▲|INTU342.64+2.20 (+0.65%) ▲|ISRG449.53-0.51 (-0.11%) ▼|JNJ280.41-0.37 (-0.13%) ▼|JPM343.39+1.32 (+0.39%) ▲|KO97.57+0.66 (+0.68%) ▲|LIN526.55+4.77 (+0.91%) ▲|LLY1,437.29+5.00 (+0.35%) ▲|LMT610.05+6.93 (+1.15%) ▲|LOW231.60-0.27 (-0.12%) ▼|LRCX235.88+13.49 (+6.07%) ▲|MA660.73+1.89 (+0.29%) ▲|MCD274.80-7.37 (-2.61%) ▼|MDLZ66.70+0.16 (+0.24%) ▲|MDT101.61+0.02 (+0.02%) ▲|META628.77-12.62 (-1.97%) ▼|MMM188.88-0.49 (-0.26%) ▼|MO77.39+1.05 (+1.38%) ▲|MRK147.18-0.87 (-0.59%) ▼|MS190.61+3.05 (+1.63%) ▲|MSFT521.13-12.04 (-2.26%) ▼|MU811.30+86.19 (+11.89%) ▲|NEE85.99-0.28 (-0.32%) ▼|NFLX64.54+1.28 (+2.02%) ▲|NKE38.32-0.35 (-0.91%) ▼|NOW102.76+3.15 (+3.16%) ▲|NVDA173.73+4.93 (+2.92%) ▲|ORCL128.38+10.40 (+8.82%) ▲|PEP143.94+0.33 (+0.23%) ▲|PFE29.45+0.09 (+0.31%) ▲|PG167.67-0.99 (-0.59%) ▼|PLTR172.40+3.58 (+2.12%) ▲|PM196.35+2.10 (+1.08%) ▲|QCOM176.57+3.04 (+1.75%) ▲|RTX201.29+1.02 (+0.51%) ▲|SBUX109.89-0.06 (-0.05%) ▼|SCHW92.78-0.25 (-0.27%) ▼|SO93.84+0.19 (+0.20%) ▲|SPG234.75+0.27 (+0.12%) ▲|T22.26+0.32 (+1.46%) ▲|TMO717.71-0.49 (-0.07%) ▼|TMUS172.16+3.08 (+1.82%) ▲|TSLA390.84+11.06 (+2.91%) ▲|TXN309.81+9.29 (+3.09%) ▲|UBER70.68+0.63 (+0.90%) ▲|UNH402.94-2.18 (-0.54%) ▼|UNP302.11+1.49 (+0.50%) ▲|UPS112.45+1.40 (+1.26%) ▲|USB60.70-0.05 (-0.08%) ▼|V425.55+2.55 (+0.60%) ▲|VZ46.60+0.29 (+0.63%) ▲|WFC85.80+0.04 (+0.05%) ▲|WMT125.67+0.12 (+0.10%) ▲|XOM166.71+2.24 (+1.36%) ▲|AAPL355.63+7.12 (+2.04%) ▲|ABBV294.98+1.09 (+0.37%) ▲|ABT109.29-1.17 (-1.06%) ▼|ACN253.66-4.85 (-1.88%) ▼|ADBE237.60+0.90 (+0.38%) ▲|AMAT395.08+22.55 (+6.05%) ▲|AMD552.90+37.69 (+7.32%) ▲|AMGN468.11+2.88 (+0.62%) ▲|AMT190.24-0.13 (-0.07%) ▼|AMZN266.17-4.70 (-1.74%) ▼|AVGO345.22+13.24 (+3.99%) ▲|AXP323.11-0.35 (-0.11%) ▼|BA174.54+1.16 (+0.67%) ▲|BAC50.67-0.01 (-0.02%) ▼|BKNG160.21+0.95 (+0.60%) ▲|BLK1,226.31+4.16 (+0.34%) ▲|BMY62.91+0.11 (+0.18%) ▲|BNY152.69+1.55 (+1.03%) ▲|BRK-B588.24+4.90 (+0.84%) ▲|C124.21+1.94 (+1.59%) ▲|CAT601.61+17.04 (+2.92%) ▲|CL98.00-0.09 (-0.09%) ▼|CMCSA25.02+0.27 (+1.09%) ▲|COF197.11+1.27 (+0.65%) ▲|COP137.86+2.27 (+1.67%) ▲|COST1,087.61+21.47 (+2.01%) ▲|CRM218.01+4.53 (+2.12%) ▲|CSCO100.76+2.61 (+2.66%) ▲|CVS89.52+0.51 (+0.57%) ▲|CVX213.28+2.06 (+0.98%) ▲|DE691.75+4.11 (+0.60%) ▲|DHR235.31-0.80 (-0.34%) ▼|DIS119.65+0.44 (+0.37%) ▲|DUK128.77-0.17 (-0.13%) ▼|EMR167.06-0.48 (-0.29%) ▼|FDX322.63+3.15 (+0.99%) ▲|GD367.22-0.22 (-0.06%) ▼|GE342.75+4.84 (+1.43%) ▲|GEV808.24+11.20 (+1.41%) ▲|GILD169.73-1.14 (-0.67%) ▼|GM88.90+0.21 (+0.24%) ▲|GOOG290.63+5.71 (+2.00%) ▲|GOOGL293.45+6.07 (+2.11%) ▲|GS926.81+16.62 (+1.83%) ▲|HD351.31+0.31 (+0.09%) ▲|HON227.64-0.58 (-0.25%) ▼|IBM248.22+3.69 (+1.51%) ▲|INTC62.50+4.37 (+7.52%) ▲|INTU342.64+2.20 (+0.65%) ▲|ISRG449.53-0.51 (-0.11%) ▼|JNJ280.41-0.37 (-0.13%) ▼|JPM343.39+1.32 (+0.39%) ▲|KO97.57+0.66 (+0.68%) ▲|LIN526.55+4.77 (+0.91%) ▲|LLY1,437.29+5.00 (+0.35%) ▲|LMT610.05+6.93 (+1.15%) ▲|LOW231.60-0.27 (-0.12%) ▼|LRCX235.88+13.49 (+6.07%) ▲|MA660.73+1.89 (+0.29%) ▲|MCD274.80-7.37 (-2.61%) ▼|MDLZ66.70+0.16 (+0.24%) ▲|MDT101.61+0.02 (+0.02%) ▲|META628.77-12.62 (-1.97%) ▼|MMM188.88-0.49 (-0.26%) ▼|MO77.39+1.05 (+1.38%) ▲|MRK147.18-0.87 (-0.59%) ▼|MS190.61+3.05 (+1.63%) ▲|MSFT521.13-12.04 (-2.26%) ▼|MU811.30+86.19 (+11.89%) ▲|NEE85.99-0.28 (-0.32%) ▼|NFLX64.54+1.28 (+2.02%) ▲|NKE38.32-0.35 (-0.91%) ▼|NOW102.76+3.15 (+3.16%) ▲|NVDA173.73+4.93 (+2.92%) ▲|ORCL128.38+10.40 (+8.82%) ▲|PEP143.94+0.33 (+0.23%) ▲|PFE29.45+0.09 (+0.31%) ▲|PG167.67-0.99 (-0.59%) ▼|PLTR172.40+3.58 (+2.12%) ▲|PM196.35+2.10 (+1.08%) ▲|QCOM176.57+3.04 (+1.75%) ▲|RTX201.29+1.02 (+0.51%) ▲|SBUX109.89-0.06 (-0.05%) ▼|SCHW92.78-0.25 (-0.27%) ▼|SO93.84+0.19 (+0.20%) ▲|SPG234.75+0.27 (+0.12%) ▲|T22.26+0.32 (+1.46%) ▲|TMO717.71-0.49 (-0.07%) ▼|TMUS172.16+3.08 (+1.82%) ▲|TSLA390.84+11.06 (+2.91%) ▲|TXN309.81+9.29 (+3.09%) ▲|UBER70.68+0.63 (+0.90%) ▲|UNH402.94-2.18 (-0.54%) ▼|UNP302.11+1.49 (+0.50%) ▲|UPS112.45+1.40 (+1.26%) ▲|USB60.70-0.05 (-0.08%) ▼|V425.55+2.55 (+0.60%) ▲|VZ46.60+0.29 (+0.63%) ▲|WFC85.80+0.04 (+0.05%) ▲|WMT125.67+0.12 (+0.10%) ▲|XOM166.71+2.24 (+1.36%) ▲|
13.1 C
New York
Thursday, November 12, 2026

Tag: growth

Appili Therapeutics Reports Fiscal Year 2025 Financial and Operational Results

LIKMEZ™ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing  

Hapbee Announces CDN$1.5M Private Placement Led by Company Executive; Announces Appointment of Ahsan Ashraf as Chief Technology Officer

VANCOUVER, British Columbia, June 25, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or the “Company”), the digital wellness technology company, is pleased to announce a non-brokered private placement consisting of up to 15,070,000 units (“Units”) at a price of $0.10 per Unit for aggregate gross proceeds of up to $1,507,000 (the “Offering”). Each Unit will consist of one subordinate voting common share of the Company (a “Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will be exercisable for one additional Share of the Company at a price of $0.20 CAD for two years from the date of issuance.

DHODH Inhibitors Market Forecast to Reach New Heights by 2034 Owing to the Expanding Applications in Oncology and Autoimmune Diseases | DelveInsight

The DHODH inhibitor market is poised for steady growth, fueled by the rising burden of autoimmune and inflammatory diseases, along with increasing interest in...

DHODH Inhibitors Market Forecast to Reach New Heights by 2034 Owing to the Expanding Applications in Oncology and Autoimmune Diseases | DelveInsight

The DHODH inhibitor market is poised for steady growth, fueled by the rising burden of autoimmune and inflammatory diseases, along with increasing interest in...

10 ARTS Foundation and NYFA Launch Groundbreaking Creative Arts Program for NYC Veterans

Announcing the launch of the PFC Joseph P. Dwyer Veterans Creative Arts Program
Announcing the launch of the PFC Joseph P. Dwyer Veterans Creative Arts Program

Organic Spirulina Market to Reach $515 Million by 2035, Growing at a CAGR of 13.5% from 2025, Says Meticulous Research®

Market Growth Driven by Rising Consumer Preference for Clean-Label Products, Premium Health Benefits, Expanding Organic Nutraceuticals Industry, and Growing Demand for Natural Food Colorants REDDING,...

Organic Spirulina Market to Reach $515 Million by 2035, Growing at a CAGR of 13.5% from 2025, Says Meticulous Research®

Market Growth Driven by Rising Consumer Preference for Clean-Label Products, Premium Health Benefits, Expanding Organic Nutraceuticals Industry, and Growing Demand for Natural Food Colorants REDDING,...

Federal Realty Investment Trust Announces Second Quarter 2025 Earnings Release Date and Conference Call Information

NORTH BETHESDA, Md., June 25, 2025 /PRNewswire/ -- Federal Realty Investment Trust (NYSE:FRT) will announce second quarter 2025 earnings in a press release to...

ALIMENTATION COUCHE-TARD ANNOUNCES ITS RESULTS FOR ITS FOURTH QUARTER AND FISCAL YEAR 2025

LAVAL, QC, June 25, 2025 /PRNewswire/ - Alimentation Couche-Tard Inc. ("Couche-Tard" or the "Corporation") (TSX: ATD) announces its results for its fourth quarter ended April 27, 2025. ...

ALIMENTATION COUCHE-TARD ANNOUNCES ITS RESULTS FOR ITS FOURTH QUARTER AND FISCAL YEAR 2025

LAVAL, QC, June 25, 2025 /CNW/ - Alimentation Couche-Tard Inc. ("Couche-Tard" or the "Corporation") (TSX: ATD) announces its results for its fourth quarter ended April 27, 2025. ...

CVB Financial Corp. Announces 143rd Consecutive Quarterly Cash Dividend

Ontario, CA, June 25, 2025 (GLOBE NEWSWIRE) -- CVB Financial Corp. (NASDAQ: CVBF) (the “Company”) announced a twenty cent ($0.20) per share cash dividend with respect to the second quarter of 2025. This dividend was approved at the Company’s regularly scheduled Board of Directors meeting held on June 25, 2025. The quarterly dividend will be payable on or about July 24, 2025 to shareholders of record as of July 10, 2025.

Sunrun Dispatches More Than 340 Megawatts of Power in Single Evening to Support the Grid from Coast to Coast

As many parts of the country grapple with a triple-digit heat wave, Sunrun answers urgent requests to dispatch critical energy from home batteries paired with solar
As many parts of the country grapple with a triple-digit heat wave, Sunrun answers urgent requests to dispatch critical energy from home batteries paired with solar

Hapbee Issues Clarification of June 24, 2025 Press Release on Q1 2025 Financial Results

Following a 198% sales surge in Q4, Hapbee added 191% revenue growth in Q1 2025 while reducing operating expenses by 62%
Following a 198% sales surge in Q4, Hapbee added 191% revenue growth in Q1 2025 while reducing operating expenses by 62%

Kodiak Sciences to Present KSI-101 Highlights at 2025 Congress of the International Ocular Inflammation Society

PALO ALTO, Calif., June 25, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsGrowth